No Detail Found!

Label-free quantification based proteomic analysis of serum obtained from henoch- schönlein purpura patients before and after zhenbao pill treatment

Author(s)
Wuritunashun Afiliated Hospital of Inner Mongolia University for the Nationalities,T ongliao, Inner Mongolia 028000,China
Burenbatu Afiliated Hospital of Inner Mongolia University for the Nationalities,T ongliao, Inner Mongolia 028000,China
Narenqiqige Afiliated Hospital of Inner Mongolia University for the Nationalities,T ongliao, Inner Mongolia 028000,China
Jiuguniang Afiliated Hospital of Inner Mongolia University for the Nationalities,T ongliao, Inner Mongolia 028000,China
Eerdunduleng Afiliated Hospital of Inner Mongolia University for the Nationalities,T ongliao, Inner Mongolia 028000,China
Shuanglian Wang Afiliated Hospital of Inner Mongolia University for the Nationalities,T ongliao, Inner Mongolia 028000,China
Cuiqin Gong Afiliated Hospital of Inner Mongolia University for the Nationalities,T ongliao, Inner Mongolia 028000,China
Hashengaowa Afiliated Hospital of Inner Mongolia University for the Nationalities,T ongliao, Inner Mongolia 028000,China
Huizhi Jin Afiliated Hospital of Inner Mongolia University for the Nationalities,T ongliao, Inner Mongolia 028000,China
Baiwurihan Afiliated Hospital of Inner Mongolia University for the Nationalities,T ongliao, Inner Mongolia 028000,China
Chunhaizi Afiliated Hospital of Inner Mongolia University for the Nationalities,T ongliao, Inner Mongolia 028000,China
Abstract
Henoch-Schönlein Purpura (HSP), also known as immunoglobulin A vasculitis, is an immune disorder that is predominantly seen in children (8-20/100000 each year) worldwide. It is characterized by inflammation and bleeding of tiny blood vessels in the skin, joints, intestines, and kidneys. The most distinctive characteristic of this type of vasculitis is a purple rash that often afects the thighs and buttocks. The Zhenbao pill, containing several medicinally important compounds, has been found to be efective against a variety of neurological and immunological illnesses. We used a label-free quantification (LFQ) proteomics approach to investigate the efect of the Zhenbao pill on the diferential serum protein expression of HSP patients. Out of 14 significantly diferentially expressed proteins, four proteins immunoglobulin lambda variable 3-27, immunoglobulin kappa variable 3-11, neural cell adhesion molecule L1-like protein, and immunoglobulin heavy variable 3-33 were upregulated, whereas 10 proteins i.e., protein Z-dependent protease inhibitor, C4b-binding protein alpha chain, heparin cofactor 2, complement C4A, complement C4 beta chain, vitamin K-dependent protein Z, coagulation factor VII, proteoglycan 4, lipopolysaccharide-binding protein (LBP), thrombospondin-4, and plasminogen activator inhibitor 1 were downregulated. Bioinformatics analysis of these diferentially expressed proteins revealed that they play a critical role in immune-related responses. Parallel reaction monitoring validation also substantiated the results of the LFQ proteomics approach by analyzing the expression of LBP and SERPINA10. This work identifies the proteins and protein-related molecular pathways that are responsible for the eficacy of Zhenbao pill in the management of HSP.
Publication Details
Page(s) 1383-1392
Published Journal: Pakistan Journal of Zoology, Volume: 55, Issue: 3, Year: 2023

Request the full text from PASTIC

Keywords
immunity, Henoch-Schönlein purpura, therapeutic strategies, Zhenbao pill, LFQ proteomics
0

Citations

0

Downloads

65

Views